Baclofen /day

Phase 3Small molecule

CCentre for Addiction and Mental Health

Baclofen /day is one of 33 small molecule programs targeting Alcoholic Liver Disease. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Alcoholic Liver DiseaseActive, not recruiting

Smoking CessationActive, not recruiting

Alcoholic Liver DiseasePhase 3

Active, not recruiting

Smoking CessationPhase 2

Active, not recruiting

Competition

Competitive Landscape

154 competitors in Smoking Cessation

#DrugCompanyPhaseTrials

Wellbutrin

GSK

Phase 3

5 2

Chantix

Pfizer

Phase 3

3 3

Ozempic

Novo Nordisk

Phase 3

2 4

Topamax

WWim Janssens

Phase 3

3 5

Rimonabant

Sanofi

Phase 3

5 6

Lopid

Pfizer

Phase 2

1 7

Standard Treatment

Boehringer Ingelheim

Phase 3

1 8

Pharmacotherapy

UUniversity of Pittsburgh

Phase 3

1 9

Selincro

IIndivior Inc.

Phase 2

1 10

Zocor

OOrganon and Co

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Alcoholic Liver Disease1 trial

Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease

Completed·SSouth West Sydney Local Health District·Phase 3·NCT01711125·104 enrolled

Smoking Cessation1 trial

Baclofen for Smoking Cessation in a Non-Psychiatric Population

Terminated·CCentre for Addiction and Mental Health·Phase 2·NCT01228994·6 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Baclofen /day. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Baclofen /day compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Baclofen /day. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Centre for Addiction and Mental Health company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: CCentre for Addiction and Mental Health

Baclofen /day

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Alcoholic Liver Disease1 trial

Smoking Cessation1 trial

References

Drug Info

Quick Facts

Related News